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Abstract 
Background: Major depressive episodes (MDE) are frequent at the population level and are generally associated with 
severe symptoms that impair performance of activities of daily living of individuals suffering from this condition. The 
aim of this study was to compare the accuracy of two tests that separately showed suitable properties in screening for 
MDE: the Patient Health Questionnaire-9 (PHQ-9) and the Edinburgh Postnatal Depression Scale (EPDS).
Methods: In a previous study, the sensitivity and specificity of the PHQ-9 and the EPDS in screening for MDE were 
compared with a structured diagnostic interview conducted by psychiatrics and psychologists using the Mini Interna-
tional Neuropsychiatric Interview as the gold standard. In a sample of adults living in the community in Pelotas, Brazil, 
the PHQ-9 and EPDS were applied at the same interview and the gold standard on a median of 17 days later. The 
interviews were carried out at the participant’s home.
Results: 447 Individuals (191 men and 256 women) were assessed. The PHQ-9 and the EPDS results were con-
cordant in 87.5% of the respondents, with a moderate agreement beyond what was expected by chance alone 
(kappa = 0.61). The areas below the ROC curves were not statistically different (82.1% for PHQ-9 and 83.5% for EPDS) 
(p = 0.291), thus indicating that the two tests had similar moderate accuracy.
Conclusions: PHQ-9 and EPDS may be applied with equal confidence in screening for MDE in the community.
Keywords: Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale, Major depressive episode, 
Screening, Accuracy
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Background
Major depressive episodes (MDE) are frequent at the 
population level and are generally associated with severe 
symptoms that impair performance of activities of daily 
living of individuals suffering from this condition [1, 2]. 
Worldwide, population-based surveys that included 
more than 37,000 individuals living in ten countries on 
four continents have recorded lifetime prevalence of 
MDE ranging from 8 to 12% [3].
The age of depressive symptoms onset is in the mid-
dle 20s, with the peak risk period for onset ranging from 
mid-late adolescence to early 40s [1, 3]. The approxi-
mately twofold increase in risk of depression among the 
women in comparison to the men is consistent over cul-
tures and most age groups [4]. Conjugal situation (more 
frequent among individuals who are unmarried and live 
without a partner) and family genetic factors (parental 
depression increases the risk of the offspring also devel-
oping depressive episodes) are recognized risk factors 
for MDE [1, 3]. Epidemiological studies using a range of 
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different methods have documented higher overall rates 
of depression over time, with increasing rates in the 
young, associated with a shift forward to younger ages 
[1]. Although older individuals may be less likely to rec-
ognize depression as a mental disorder, and hence are 
less likely to remember depressive episodes as such, or 
to report these episodes in interviews on mental health 
[5], the evidence that rates of depression in the elderly are 
higher compared with those observed in past studies sug-
gest the presence of a cohort effect.
A number of adverse consequences of major depres-
sion have been described. School failure, low probability 
of ever marrying or higher probability of early marital 
timing and divorce, teen childbearing, negative parent-
ing behaviors, work absenteeism, lower income-earnings, 
comorbidity and elevated risk of early death are all asso-
ciated with major depression [1].
Recognition of depression as a public health problem 
has led to creation of a variety of screening instruments 
for use in research and in primary healthcare services, 
with the aim of identifying individuals at risk of MDE, 
at an earlier stage [6]. Although two meta-analyses [7, 8] 
and a quasi-experimental study [9] found no evidence of 
effectiveness of screening at primary healthcare services, 
the availability of reliable and valid information is essen-
tial for estimating and monitoring depression prevalence 
and time trends in depression prevalence by means of 
epidemiological research at the population level.
Because the properties of the screening tests vary as a 
function of the socio-demographic and cultural charac-
teristics of the population to which the tests are applied, 
it is recommended that their use should be preceded by 
studies that evaluate these properties within the con-
text in which they will be used [10]. The sensitivity and 
specificity of two depression screening instruments, the 
Patient Health Questionnaire-9 (PHQ-9) [11] and the 
Edinburgh Postnatal Depression Scale (EPDS) [12], were 
evaluated on a single sample of adults living in the city of 
Pelotas, RS, Brazil, and the results have already been pub-
lished [13, 14], The objective of the present study was to 
compare the accuracy of the two tests, which separately 
showed good sensitivity and specificity in screening for 
MDE among adults living in the community.
Methods
A cross-sectional population-based study was conducted 
in the urban zone of the municipality of Pelotas between 
February and June 2012 to evaluate the health of adoles-
cents, adults and elderly people. A sampling design of 
two-stage conglomerates with probability proportional 
to size was used. According to the 2010 Population Cen-
sus there were 495 census tracts, the primary sampling 
units. The secondary sampling units were households. All 
private households with permanent resident as of Decem-
ber 2011 in the 130 census tracts randomly selected were 
listed. In each census tract drawn, around 12 households 
were randomly selected for the survey. All the people liv-
ing in the households drawn who were 10 years of age or 
over were eligible. The participants were interviewed at 
home, by trained interviewers, through applying a struc-
tured questionnaire that included questions about their 
economic condition, schooling, marital status, skin color, 
occupation, health, and behavior. The adults (≥20  years 
of age) answered the PHQ-9 and EPDS questionnaires, 
and these were applied by general interviewers. Individu-
als who had cognitive or mental disabilities confirmed by 
the fieldwork supervisor, as well as those institutionalized 
(hospitals, elderly homes, among others), were excluded.
Validation studies on PHQ-9 [13] and EPDS [14] were 
conducted on a subsample of adults (≥20  years of age). 
The sampling process for the validation studies was con-
ducted weekly, starting from the interviews that were 
conducted for the main study. Through simple random 
draws, one-third of the households included in the main 
study were selected for the validation studies. The person 
in charge of the draw was unaware of the results from 
the PHQ-9 or EPDS tests that were applied in the main 
study. In each household thus selected, all the people liv-
ing there who were 20 years of age or over, independently 
of the PHQ-9 or EPDS scores, were invited to receive a 
second visit for a supplementary interview. This second 
interview was conducted by a mental health professional 
(psychiatrist, psychologist or medical resident in psy-
chiatry), who had previously been trained to apply and 
interpret the gold-standard instrument and was blind to 
the scores achieved by the participant in the PHQ-9 and 
EPDS questionnaires. The participants were unaware of 
the professional training of these interviewers, so that 
this would not influence the responses.
The PHQ-9 consists of nine questions that assess the 
presence of each of the symptoms of MDE, as described in 
the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV) [15] (depressed mood; loss of interest or pleas-
ure in doing things; problems relating to sleep, tiredness 
or lack of energy; changes in appetite or weight; feelings 
of guilt or uselessness; problems of concentration; feelings 
of being slow or restless; and suicidal thoughts). The fre-
quency of each symptom over the preceding 2 weeks was 
evaluated on a Likert scale from 0 to 3.
The EPDS was originally constructed to identify post-
partum depression, but it can be applied to screen for 
depression in the community, including among men [16]. 
The EPDS consists of a scale of 10 items, each with four 
possible responses from 0 to 3, which express the inten-
sity of depressive symptoms over the 7  days preceding 
the interview.
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The questionnaire for the first interview (main study) 
was set up in sections. The PHQ-9 was applied after the 
participants had answered the questions in the sections 
relating to socio-demographic factors, behavioral factors, 
chronic diseases and use of medications. Following the 
PHQ-9 application, there were questions on the subjects’ 
use of and access to healthcare services and their dietary 
habits, and then the EPDS was applied. Further details on 
the methodology of the validation studies for the PHQ-9 
and EPDS, along with the Portuguese-language versions 
used, can be obtained in other published papers [13, 14].
To calculate the sample size, the following parameters 
were used: sensitivity and specificity of 80%, accept-
able error of 10% points upwards or downwards and sig-
nificance level of 95%. Thus it was necessary to include 
around 200 subjects with MDE and 200 without MDE. 
Given that the point-prevalence of depressive symptoms 
among the adult population of Pelotas had been found to 
be around 30% [17], it was estimated that with a sample 
of around 600 individuals, it would be possible to locate 
around 200 with MDE.
The gold standard used was the Mini International 
Neuropsychiatric Interview (MINI) [18], which has been 
validated for use in Brazil [19]. This structured diagnostic 
questionnaire assesses the presence of mental disorders, 
in accordance with DSM-IV and ICD-10. For depressive 
disorders, it has sensitivity and specificity of 92% [19]. In 
the present study, the gold standard was used to diagnose 
the presence of MDE. All individuals who were consid-
ered to be positive for MDE gave responses to an addi-
tional group of questions that investigated other possible 
causes for the symptoms, such as direct effects of sub-
stances, organ disorders, medical illness or presence of 
psychotic symptoms, or whether the symptoms would be 
better explained as reactions to grief, for which the diag-
nosis of MDE would be rejected.
The data analysis included calculation of the sensitivity 
and specificity for each score on a continuous scale for 
each of the tests. For each PHQ-9 and EPDS cutoff point, 
the sensitivity (proportion of individuals with MDE 
according to MINI criteria that were correctly identified 
by the test), specificity (proportion of individuals without 
MDE according to the gold standard correctly identified 
as such by the test), positive predictive value (propor-
tion of true positives among all positives identified by the 
test), accuracy (proportion of true positives and true neg-
atives identified by the test), and positive likelihood ratio 
(the odds that the given cutoff point would be expected 
in an individual with in opposed to one without MDE 
according to the gold standard) with 95% confidence 
intervals were calculated.
To compare the accuracy of the tests for identify-
ing individuals at risk of MDE, the sensitivity and 
1-specificity values of each of the cutoff points for the 
PHQ-9 and EPDS were plotted on a single receiver oper-
ating characteristic (ROC) curve. The cutoff point with 
greatest sensitivity and specificity on the ROC curve was 
defined as the lowest value for the equation {(1 − sensi-
tivity)2 + (1 − specificity)2}. The accuracies of the PHQ-9 
and EPDS were compared by means of the areas under 
the respective ROC curves. The concordance between 
the two tests, i.e. beyond what would be expected by 
chance, was calculated by means of the kappa statistic.
The main study and the validation studies were 
approved by the Research Ethics Committee of the 
School of Medicine, Federal University of Pelotas, in 
accordance with protocols 77/2011 and 14/2012, respec-
tively. A free and informed consent statement was signed 
by each participant in the main study before informa-
tion was gathered. The individuals who were diagnosed 
as positive through the gold-standard assessment were 
attended at home and/or were referred to the healthcare 
services.
Results
A total of 533 individuals were identified as candidates 
for the gold-standard interview. Of these, 447 (84%) were 
assessed: there were 29 refusals; 51 were deemed to be 
losses after three attempts to find them; and six were 
found to have moved away from this municipality. The 
interviews with mental health professionals (gold stand-
ard) were held on average 24 days after application of the 
two tests (median of 17 days).
The individuals evaluated comprised 191 men and 
256 women. The majority (83.2%) were under the age 
of 60 years and 76.5% self-declared as having white skin 
color. With regard to socioeconomic variables, more 
than one-third (39.7%) were living in families with mean 
monthly incomes ≤3 minimum wages and 15.3% had 
only attended school until the fourth year of elementary 
school. More than half of the participants were doing 
paid work at the time when the PHQ-9 and EPDS were 
applied (58.8%) and were living with partners (65.5%).
The individuals who were lost from the gold-standard 
interview were similar to those who were interviewed 
by the general interviewers, with regard to all the char-
acteristics investigated, except in relation to paid work. 
The frequency of unemployment among individuals 
evaluated by means of the gold standard was greater than 
when the PHQ-9 and EPDS were applied (respectively, 
60.4 and 41.2%).
The gold-standard interview identified 40 individu-
als (32 women and eight men) presenting MDE (8.9%; 
6.3–11.6%). For the PHQ-9, values ≥9 were more accu-
rate for identifying individuals at greater risk of present-
ing MDE (Fig. 1). At this point, the sensitivity was 77.5% 
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(61.5–89.2%), specificity 86.7% (83.0–89.9%), positive 
predictive value 36.5% (26.3–47.6%), and positive likeli-
hood ratio 5.8 (4.3–7.9) (Table 1). A total of 85 individ-
uals (19.0%) scored ≥9. The area under the ROC curve 
indicated a general test accuracy of 82.1%.
For the EPDS, the best cutoff score was ≥8 (Fig.  1), 
and this value was reached by 85 individuals (19.0%). The 
crude concordance between the two tests was 87.5%, with 
a moderate kappa value (0.61). The sensitivity of EPDS 
≥8 was 80.0% (64.4–90.9%), specificity 87.0% (83.3–
90.1%), positive predictive value 37.6% (27.4–48.8%), 
and positive likelihood ratio 6.1 (4.6–8.3) (Table 1). The 
area under the ROC curve showed a general accuracy of 
83.5%, i.e. similar to that of the PHQ-9 (p = 0.291).
Discussion
The areas under the curves, and also their formats, indi-
cated that the PHQ-9 and EPDS presented similar and 
moderate accuracy with regard to identifying adults 
living in the community who were at greater risk of 
presenting MDE. Such a finding is in line with the results 
of a systematic review planned to examine the accuracy 
of depression screening instruments (including PHQ-9 
and EPDS), which concluded that no single instrument 
was superior to another [20].
In the current study, the two tests were concordant in 
391 (87.5%) of the 447 respondents. Good concordance 
between the tests was seen even with symptom recall 
times for the two scales differing by 1 week. Similar level 
of agreement (83%) was reported by Yawn et al. [21] in a 
study specifically planned to compare the PHQ-9 and 
EPDS as screening tools for postpartum depression. The 
natural history of the depression may have contributed 
towards the comparability of the two tests, given that once 
manifested, the depressive symptoms tend to persist for 
weeks (with a median duration of 3 months) and, in 20% 
of the cases, they remain chronic for 2 years or more [22].
Out of the 85 individuals who were screened positive 
through the PHQ-9, 57 (67.1%) were also positive accord-
ing to the EPDS. Among the 56 individuals for whom the 
two tests had discordant results, the gold standard indi-
cated that in half of the cases, the PHQ-9 result was cor-
rect and in the other half, the EPDS result. Further work 
is required to identify reasons for disagreement.
The positive likelihood ratios, both for the PHQ-9 
and for the EPDS, were around six, thus indicating that 
results from these tests that are ≥9 and ≥8, respectively, 
are six times more likely to occur among individuals with 
MDE, in consultations with mental health profession-
als, than among individuals without MDE. The positive 
predictive values for the two tests were also very simi-
lar (36.5%; 26.3–47.6% for PHQ-9 at the cutoff ≥9; and 
37.6%; 27.4–48.8% for EPDS ≥8). Thus, if these two tests 
are applied for population screening, they will be equally 
efficient: two in every five individuals with positive 
screening through either of the tests will present MDE.
Among the limitations of this study, 16% of individu-
als could not undergo the gold standard interview and, 
though, were not included in the validation sample. They 
were similar to those included in the sample regarding all 
socioeconomic, demographic and behavioural character-
istics investigated, except to be employed. The prevalence 
of PHQ-9 ≥9 and EPDS ≥8 among people that failed to 
be included in the validation sample was similar to those 
included in the sample (22.1 vs 19.0%, p  =  0.510 for 
PHQ-9; and 24.4 vs 19.0%, p = 0.250, for EPDS, respec-
tively). It looks like the loss of these individuals may not 
have impaired the sensitivity estimation in the present 
study. Additionally, in regard to ethical aspects, neither 
the lost individuals nor those that refused to attend the 
gold standard interview had replied positively to the 
questions on risk of suicide of both the PHQ-9 and EPDS 
questionnaires.
Fig. 1 Receiver operating characteristic (ROC) curves of the Patient 
Health Questionnaire (PHQ-9) and Edinburgh Postnatal Depres-
sion Scale (EPDS) for screening for major depressive episodes 
among adults living in the community. Areas under the ROC curve: 
PHQ-9 = 0.821; EPDS = 0.835
Table 1 Properties and  95% confidence intervals of  the 
Patient Health Questionnaire-9 (PHQ-9) and  Edinburgh 
Postnatal Depression Scale (EPDS), at  the cutoff points 
of  maximum sensitivity and  specificity for  screening 
for MDE among adults in the community
MDE major depressive episode, PPV positive predictive value, PLR positive 
likelihood ratio
Instrument Sensitivity Specificity PPV PLR
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Both the PHQ-9 and the EPDS were applied in the 
middle of the interview. There were questions on the 
subjects’ use of and access to healthcare services, as well 
as on their dietary habits between the PHQ-9 and the 
EPDS application. However, the fact that both tests were 
applied to the same sample, in the same interview and in 
sequence may have jogged the interviewees’ memories 
with regard to answering the questions of the EPDS, in 
comparison with the PHQ-9, given that the PHQ-9 was 
applied first. It is possible that this may have introduced 
some information bias.
Another limitation was the gap of about 17  days 
(median) between the PHQ-9 and EPDS application and 
the gold standard administration. Because the validation 
studies were nested within a large epidemiological study 
with a complex logistics, a delay on the execution of some 
of the implementation steps was difficult to prevent. It 
is possible that depressive symptoms may have changed 
over this period due to two main reasons. First, the 
PHQ-9 and EPDS were designed to enquire about feel-
ings over the last fifteen and the last 7 days, respectively. 
Second, the duration of the MDE may vary with age 
and with the natural history of the disorder [4]. Recur-
rent depression typically has shorter episode duration. 
The young have more frequent episodes of shorter dura-
tion whereas the elderly has long episodes and chronic 
depression. However, the reported median duration of 
MDE in the community is 3 months [23], what may have 
minimized at least in part the negative effect of the time 
lag over the observed sensitivity of the PHQ-9 and EPDS.
Despite the standardization procedures undertaken 
before the study initiation, another flaw is the lack of 
assessment of the inter-rater reliability of the gold-stand-
ard evaluators.
Finally, there are concerns that EPDS is not suitable 
for men because it detects distress but not necessar-
ily depression [24], and that EPDS has a different fac-
tor structure in men [25–28]. The EPDS, as much of the 
mental screening instruments assess for common mental 
disorders including anxiety, depression and psychological 
distress [20]. In the current study the gold standard inter-
view was planned to identify true cases of MDE so that all 
cases that scored positive at the screening due to anxiety 
or psychological distress were classified as false positive 
results. According to the gold-standard, only eight of the 
191 men included in the study presented a MDE. Such a 
small prevalence prevented us from conducting separate 
analyses according to the sex of the participants.
Conclusion
In localities with socioeconomic, demographic and 
morbidity profiles similar to those of the city of 
Pelotas, both the PHQ-9 and the EPDS can be used 
confidently for screening for MDE in the community. 
Both of these tests have the advantage of containing 
few questions (nine and ten, respectively) and only 
taking around 5 min for application among adults [13, 
14].
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